Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
365-01-001.
Non-Contrast Multiparametric CMR for Predicting Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Impact: A non-contrast CMR nomogram effectively
identifies myocardial fibrosis in HCM, offering a safe, efficient, and
clinically applicable alternative to LGE for precision risk stratification and
treatment guidance.
|
||
|
365-01-002.
Low-Rank Motion-Corrected Deep Image Prior Reconstruction for Cardiac Magnetic Resonance Fingerprinting
Impact: LRMC-DIP improves image quality in the presence of cardiac motion, improving the clinical applicability of cardiac MRF to a broader patient population.
|
||
|
365-01-003.
Layer-Specific Myocardial Strain by CMR-FT Differentiates Hypertrophic Cardiomyopathy from Hypertensive Heart Disease
Impact: This
study establishes that layer-specific strain analysis provides deep
microstructural insights to differentiate hypertrophic cardiomyopathy (HCM)
from hypertensive heart disease (HHD), potentially reducing diagnostic reliance
on contrast agents and improving noninvasive differential diagnosis of left
ventricular hypertrophy.
|
||
|
365-01-004.
Non-Invasive Pressure-Volume Loop Analysis Differentiates Hypertrophic Cardiomyopathy from Hypertensive Heart Disease
Impact: Non-invasive P-V loop
analysis reveals distinct mechanical and energetic differences between HCM and
HHD, providing quantitative biomarkers for differential diagnosis beyond
morphological assessment.
|
||
|
365-01-005.
Improved 4D flow MRI quantification in Patients with Hypertrophic Cardiomyopathy Using Divergence-Free Neural Networks
Impact: Divergence-free neural networks enforce
physics-based constraints in 4D flow MRI, improving flow quantification
accuracy in hypertrophic cardiomyopathy patients. This approach enhances
clinical assessment of cardiovascular hemodynamics, demonstrating feasibility
for more reliable diagnostic imaging.
|
||
|
365-01-006.
Clinical value of CMR in the evaluation of non-ischemic dilated cardiomyopathy with functional mitral regurgitation
Impact: This study explores the potential of cardiac magnetic resonance (CMR) in evaluating patients with non-ischemic dilated cardiomyopathy (DCM) combined with functional mitral regurgitation(FMR), offering significant value for clinical diagnosis, risk stratification, and prognosis assessment.
|
||
|
365-01-007.
Prognostic Utility of Long Axis Strain for Predicting Adverse Events in Hypertrophic Cardiomyopathy
Impact: In HCM patients, the average LA- LAS and RA-LAS measured by cine CMR could independently predicted of MACEs and HF-related hospitalizations. When combined with clinical factors, average LA-LAS could improve the prediction of HF-related hospitalizations.
|
||
|
365-01-008.
Predictive value of epicardial adipose tissue for MACE in patients with DCM and analysis of its correlation with left ventric
Impact: Left
ventricular remodeling in dilated cardiomyopathy (DCM) can significantly impact
prognosis. Currently, the relationship between left ventricular (LV)
remodeling, epicardial adipose tissue (EAT) volume, and patient prognosis in
DCM patients remains unclear.
|
||
|
365-01-009.
A Comparative Study of MOLLI, ShMOLLI, and SASHA Sequences for Myocardial T1 Quantification in Dilated Cardiomyopathy
Impact: This work establishes MOLLI as the preferred T1 mapping sequence for DCM
diagnosis, providing a clear, evidence-based guideline for its clinical
implementation to ensure accurate patient evaluation.
|
||
|
365-01-010.
Quantitative oxygen consumption MRI reveals improved myocardial efficiency by mavacamtem in HOCM
Impact: Cardiac MRI-based oximetry enables direct, noninvasive quantification of myocardial oxygen metabolism in HOCM. It provides a safe, quantitative biomarker for evaluating Mavacamten response and may serve as a foundational tool to guide individualized therapy.
|
||
|
365-01-011.
Impaired Right Ventricular Strain in Hypertrophic Cardiomyopathy and Its correlation with Left Ventricular Systolic Function
Impact: This study reveals that right ventricular impairment occurs early in HCM before structural changes, which is influenced by left ventricular systolic function. These findings highlight the need to assess biventricular interaction for optimal prognosis and treatment.
|
||
|
365-01-012.
Prognostic Value of Elevated Left Ventricular Filling Pressure Detected by Cardiac MRI in Dilated Cardiomyopathy
Impact: CMR-derived LVFP is an independent predictor of adverse outcomes in DCM, providing incremental prognostic value to established clinical and CMR markers. These findings support incorporating LVFP into routine assessment, which may lead to earlier intervention and improved personalized management.
|
||
|
365-01-013.
Cardiac MRI Assessment of Ventricular Dysfunction in Severe Alcohol Use Disorder Patients
Impact: This multi-parametric CMR approach enables early detection of subclinical myocardial injury in severe AUD patients before ejection fraction decline. Identifying myocardial edema and fibrosis may guide timely intervention, potentially preventing progression to alcoholic cardiomyopathy and improving cardiovascular outcomes.
|
||
|
365-01-014.
Differentiate Fabry Disease From Hypertrophic Cardiomyopathy and Controls by Radiomics of Native T1 Mapping and MOLLI Image
Impact: Radiomics features
derived from native T1 mapping and individual MOLLI image revealed
characteristic myocardial texture patterns that distinguished FD from HCM and
controls, providing complementary insights beyond conventional T1 values and
reflecting distinct diffuse fibrosis patterns in FD.
|
© 2026 International Society for Magnetic Resonance in Medicine